MAUI, Hawaii, Oct. 4 /PRNewswire-FirstCall/ --
Bioponic Phytoceuticals, Inc. (Pink Sheets: BPYT - News; "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that it has retained OTC Financial Network, a division of National Financial Communications Corporation, as its investor relations representative.Sales of CAM reached $5 billion in 2005, and approximately 62% of U.S. adults are using some form of CAM for preventing and managing chronic disease, according to Med Ad News. Geoffrey Eiten, president of National Financial Communications, commented, "Bioponic has developed a patented, new natural healing modality and an extensive suite of branded product lines that serve explosive growth in alternative medicine."
"This is a truly an exciting revelation in Bioponic's history, and we think investors will be interested in following this company closely. We look forward to representing Bioponic to the financial community and helping it to achieve greater market exposure," added Eiten.
Steven M. Schorr, Chairman & CEO of Bioponic, said, "We have retained OTC Financial Network to help us enhance our shareholder communications and attract new investors as we capitalize on the immense growth opportunities in CAM and natural consumer products."
About OTC Financial Network
OTC Financial Network (OTCFN) has carved its niche as the nation's leading small/micro-cap investor relations and financial communications firm. OTCFN provides full-service investor relations, consulting services and customized marketing campaigns designed to maximize investor awareness for small/ micro-cap publicly traded companies. Since its inception in 1992, OTCFN has represented over 500 clients. To view a current client list or for more information, visit http://www.otcfn.com. OTCFN is a division of National Financial Communications Corp. (http://www.nationalfc.com) based in Needham, MA.
Disclaimer: OTC Financial Network (OTCFN) serves as special advisor to the featured Company and has received fees for services, including a monthly retainer of five thousand dollars, plus an option to purchase an aggregate of one million five hundred thousand shares at an exercise price of ten cents per share, plus expenses, for the creation and distribution of materials. This is not an offer to buy or sell securities. Information or opinions in this release are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Additional compensation information and a full disclaimer can be found online by visiting http://www.otcfn.com/bpyt/disclaimer.html.
About Bioponic Phytoceuticals
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines, including the nasal spray: Flight Spray® (http://www.flightspray.com) and the skincare product Hawaiian Healing Mist(TM). Bioponic is focused on the production of natural products that are used to promote health and well-being. For more information, visit http://www.bioponic.com.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, email@example.com or Geoffrey Eiten, Investor Relations, OTC Financial Network, 781-444-6100x613, firstname.lastname@example.org, www.otcfn.com/bpyt.